| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 66 |
| 1 | ASPIRIN 325 MG | 64 |
| 2 | ASPIRIN 81 MG | 64 |
| 3 | PREDNISOLONE | 60 |
| 4 | PREDNISOLONE ORAL | 60 |
| 5 | PREDNISOLONE ORAL SOLUTION | 60 |
| 6 | METHOTREXATE SODIUM | 45 |
| 7 | METHOTREXATE | 43 |
| 8 | WARFARIN | 39 |
| 9 | TACROLIMUS | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORAMPHENICOL SODIUM SUCCINATE | 1 | 0.0303 |
| 1 | IOBENGUANE I-123 | 1 | 0.0088 |
| 2 | METEX | 2 | 0.0053 |
| 3 | SODIUM PHENYLBUTYRATE | 2 | 0.0047 |
| 4 | EPTIFIBATIDE | 2 | 0.0026 |
| 5 | TRIMIPRAMINE MALEATE | 1 | 0.0025 |
| 6 | CEFPODOXIME PROXETIL | 2 | 0.0020 |
| 7 | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0016 |
| 8 | ETHIODIZED OIL | 2 | 0.0015 |
| 9 | HYDRALAZINE HYDROCHLORIDE | 4 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 122 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 104 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 68 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 43 |
| 4 | Benzodiazepine [EPC] | 35 |
| 5 | Factor Xa Inhibitor [EPC] | 33 |
| 6 | Proton Pump Inhibitor [EPC] | 33 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 32 |
| 8 | Calcium Channel Blocker [EPC] | 30 |
| 9 | Alkylating Drug [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 1 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 4 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 6 | Gonadotropin [EPC] | 1 | 0.0005 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 10 | 0.0004 |
| 8 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |